- Home
- INTS vs ILAG Comparison
INTS vs ILAG Comparison
Compare INTS & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- ILAG
- Stock Information
- Founded
- INTS 2012
- ILAG 1981
- Country
- INTS United States
- ILAG Hong Kong
- Employees
- INTS N/A
- ILAG N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- ILAG Office Equipment/Supplies/Services
- Sector
- INTS Health Care
- ILAG Consumer Discretionary
- Exchange
- INTS Nasdaq
- ILAG Nasdaq
- Market Cap
- INTS 8.7M
- ILAG 7.2M
- IPO Year
- INTS 2023
- ILAG 2022
- Fundamental
- Price
- INTS $0.50
- ILAG $0.39
- Analyst Decision
- INTS Strong Buy
- ILAG
- Analyst Count
- INTS 3
- ILAG 0
- Target Price
- INTS $8.50
- ILAG N/A
- AVG Volume (30 Days)
- INTS 396.2K
- ILAG 2.7M
- Earning Date
- INTS 05-13-2025
- ILAG 05-27-2025
- Dividend Yield
- INTS N/A
- ILAG N/A
- EPS Growth
- INTS N/A
- ILAG N/A
- EPS
- INTS N/A
- ILAG N/A
- Revenue
- INTS N/A
- ILAG $7,506,551.00
- Revenue This Year
- INTS N/A
- ILAG N/A
- Revenue Next Year
- INTS N/A
- ILAG N/A
- P/E Ratio
- INTS N/A
- ILAG N/A
- Revenue Growth
- INTS N/A
- ILAG 16.50
- 52 Week Low
- INTS $0.50
- ILAG $0.35
- 52 Week High
- INTS $5.28
- ILAG $1.35
- Technical
- Relative Strength Index (RSI)
- INTS 18.57
- ILAG 48.98
- Support Level
- INTS $0.46
- ILAG $0.34
- Resistance Level
- INTS $0.59
- ILAG $0.98
- Average True Range (ATR)
- INTS 0.05
- ILAG 0.08
- MACD
- INTS 0.02
- ILAG 0.00
- Stochastic Oscillator
- INTS 21.14
- ILAG 7.81
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.